Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Atorwel 20
Atorwel 20 (Atorvastatin Tablets 20 mg) is a prescription medication designed to manage hyperlipidemia and prevent cardiovascular diseases. As a potent HMG-CoA reductase inhibitor, it effectively lowers cholesterol levels, reducing the risk of heart attacks and strokes. Recommended as part of a comprehensive lipid-lowering strategy, Atorwel 20 is essential for patients with high cholesterol, dyslipidemia, and those at risk of atherosclerosis.
Uses of Atorwel 20
Treatment of primary hypercholesterolemia and mixed dyslipidemia
Prevention of cardiovascular events in patients with risk factors such as hypertension, diabetes, or a family history of coronary artery disease
Reduction of total cholesterol, LDL-C, triglycerides, and apolipoprotein B levels
Increase in HDL-C to promote better lipid balance
Benefits of Atorwel 20
Proven efficacy in lowering LDL cholesterol by up to 60%
Reduces the risk of myocardial infarction and stroke
Supports long-term cardiovascular health when combined with diet and exercise
Well-tolerated with a favorable safety profile in clinical trials
Mechanism of Action of Atorwel 20
Atorwel 20 acts by selectively inhibiting HMG-CoA reductase, a key enzyme in hepatic cholesterol biosynthesis. This leads to an upregulation of LDL receptors, enhancing LDL clearance from the bloodstream. The result is a significant reduction in circulating cholesterol and a lower risk of atherosclerotic plaque formation, ultimately protecting against cardiovascular complications.